Estimating the workload associated with symptoms-based ovarian cancer screening in primary care: an audit of electronic medical records

Table 2 Estimated proportion of women presenting during the week who would be offered symptoms-based ‘screening’ according to different testing thresholds

	Chrisp Street		Woosehill		Northcroft		Boundary		TOTAL
	(n =168)		(n =85)		(n =163)		(n =59)		(n =475)
	n (%)	95% CI	n (%)	95% CI	n (%)	95% CI	n (%)	95% CI	n (%)	95% CI
Any OC symptom	27 (16.1%)	10.9, 22.5	14 (16.5%)	9.3, 26.1	28 (17.2%)	11.7, 23.9	11 (18.6%)	9.7, 30.9	80 (16.8%)	13.6, 20.5
Any NICE symptom*	13 (7.7%)	4.2, 12.9	4 (4.7%)	1.3, 11.6	11 (6.7%)	3.4, 11.8	3 (5.1%)	1.1, 14.1	31 (6.5%)	4.5, 9.1
Any Index 2 symptom^†	11 (6.6%)	3.3, 11.4	3 (3.5%)	0.7, 10.0	8 (4.9%)	2.1, 9.4	3 (5.1%)	1.1, 14.1	25 (5.3%)	3.4, 7.7
≥2 Index 2 symptoms	2 (1.2%)	0.1, 4.2	0 (0%)	0.0, 4.2	2 (1.2%)	0.1, 4.4	0 (0%)	0.0, 6.1	4 (0.8%)	0.2, 2.1

OC = ovarian cancer, NICE = National Institute for Health and Clinical Excellence.
*Any one of persistent abdominal distension, feeling full (early satiety) and/or loss of appetite, pelvic or abdominal pain or increased urinary urgency and/or frequency.
^†Any one of pelvic abdominal pain or discomfort, loss of appetite, increase in abdominal size, able to feel a lump in the abdomen, or vaginal discharge.

ISSN: 2731-4553